Volume | 0 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
XOMA Corporation | XOMA | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
25.03 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 13.48 - 27.00 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
- | 0 | $ 25.03 | USD |
XOMA Corporation Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
290.99M | 11.63M | - | 4.76M | -40.83M | -3.51 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
XOMA News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical XOMA Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 25.68 | 26.29 | 24.71 | 25.21 | 14,778 | -0.65 | -2.53% |
1 Month | 25.83 | 26.79 | 23.69 | 25.30 | 10,552 | -0.80 | -3.10% |
3 Months | 24.67 | 27.00 | 23.00 | 25.27 | 15,356 | 0.36 | 1.46% |
6 Months | 15.20 | 27.00 | 14.33 | 21.15 | 21,829 | 9.83 | 64.67% |
1 Year | 19.29 | 27.00 | 13.48 | 18.67 | 28,838 | 5.74 | 29.76% |
3 Years | 31.65 | 39.02 | 13.48 | 21.21 | 29,778 | -6.62 | -20.92% |
5 Years | 16.43 | 46.32 | 13.48 | 23.41 | 38,676 | 8.60 | 52.34% |
XOMA Description
XOMA Corp is a biotechnology royalty aggregator playing a unique role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. |